Peter Múdrý
Impact in
-
- Sarcoma Diagnosis and Treatment
-
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
Papers in
-
- Sarcoma Diagnosis and Treatment 15
- Renal cell carcinoma treatment 1
- Oncology 9
- Cancer Cells and Metastasis 4
- Co-authors
- Jaroslav Štěrba (18 shared papers)Gianni Bisogno (7 shared papers)Andrea Ferrari (6 shared papers)Daniel Orbach (6 shared papers)Gian Luca De Salvo (4 shared papers)Anna Kelsey (4 shared papers)Meriel Jenney (5 shared papers)Michela Casanova (3 shared papers)
- Journals
- Cancers (3 papers)Cancer (2 papers)European Journal of Cancer (2 papers)Cancer Biomarkers (1 paper)JCO Precision Oncology (1 paper)
- Partner nations
- CzechiaFranceNetherlands
In The Last Decade
Peter Múdrý
32 papers receiving 707 citations
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 370
- Oncology 204
- Pathology and Forensic Medicine 106
- Neurology 83
- Rheumatology 68
Countries citing papers authored by Peter Múdrý
This map shows the geographic impact of Peter Múdrý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Múdrý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Múdrý more than expected).
Fields of papers citing papers by Peter Múdrý
This network shows the impact of papers produced by Peter Múdrý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Múdrý. The network helps show where Peter Múdrý may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Múdrý, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 160 | |
| 2 | 2016 | 86 | |
| 3 | 2012 | 59 | |
| 4 | 2018 | 58 | |
| 5 | 2016 | 53 | |
| 6 | 2011 | 41 | |
| 7 | 2016 | 29 | |
| 8 | 2011 | 28 | |
| 9 | 2011 | 26 | |
| 10 | 2023 | 24 | |
| 11 | 2021 | 20 | |
| 12 | 2016 | 18 | |
| 13 | 2010 | 14 | |
| 14 | 2023 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2016 | 11 | |
| 18 | 2010 | 11 | |
| 19 | 2017 | 11 | |
| 20 | 2005 | 7 |
About Peter Múdrý
Peter Múdrý is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Infectious Diseases, Epidemiology and Rheumatology, having authored 36 papers that have together received 719 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (15 papers), Antifungal resistance and susceptibility (5 papers), Bone Tumor Diagnosis and Treatments (5 papers), Fungal Infections and Studies (4 papers), Cancer Cells and Metastasis (4 papers), Oral and Maxillofacial Pathology (3 papers), Cancer Genomics and Diagnostics (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (370 citations), Oncology (204 citations), Pathology and Forensic Medicine (106 citations), Neurology (83 citations) and Rheumatology (68 citations). Peter Múdrý has collaborated with scholars based in Czechia, France and Netherlands. Frequent co-authors include Jaroslav Štěrba, Gianni Bisogno, Andrea Ferrari, Daniel Orbach, Gian Luca De Salvo, Anna Kelsey, Meriel Jenney, Michela Casanova, Johannes H. M. Merks and Christophe Bergeron. Their work appears in journals such as Cancers, Cancer, European Journal of Cancer, Cancer Biomarkers and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.